Real-world data study confirms bivalent mRNA booster vaccines associated with greater short-term protection against symptomatic COVID-19 infections in adults
Published Date: 12/19/2022
Source: sciencedaily.com
A new study has found that the bivalent booster vaccine provides greater short-term protection against symptomatic COVID-19 infections which generate emergency department and urgent care visits or hospitalization, compared to prior receipt of two, three or even four doses of first-generation vaccines without a bivalent booster vaccine.